stars 1 stars 2 stars 3

BioAgeDiagnostics is a specialised B2B precision longevity platform and distribution partner enabling healthcare providers to deliver integrated, data-driven longevity care. We provide access to advanced biological age and molecular diagnostic platforms — including multi-organ biomarker analytics and epigenetic testing — alongside a curated portfolio of regulated therapeutics, NAD+ formulations, peptides, metabolic injectables, performance compounds, and longevity-focused medical protocols. Precision longevity is built on validated biomarkers, genetic intelligence, and measurable outcomes. Genetics informs predisposition. Epigenetics reveals biological state. Therapeutics enable targeted optimisation. Through integrated diagnostic and therapeutic infrastructure, we move from isolated insights to structured longevity care — from data to intervention. By combining laboratory innovation with clinically governed therapeutic implementation, BioAgeDiagnostics enables providers to operationalise measurable, scalable healthspan optimisation across modern preventive and precision medicine frameworks.

Website https://www.bioagediagnostics.com/
Employees 4 (2 on RocketReach)
Founded 2025
Industry Biotechnology Research

BioAgeDiagnostics Questions

Bettina van Wylich-Muxoll is the Managing Partner of BioAgeDiagnostics.

2 people are employed at BioAgeDiagnostics.

Top BioAgeDiagnostics Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users